Beximco Pharmaceuticals PLC. Share Price
Stocks
BXPHARMA
BD0453BXPH04
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Dhaka S.E.
06/10/2026
|
5-day change | 1st Jan Change | ||
| 139.60 BDT | -2.24% |
|
-5.74% | +36.73% |
| 15/09 | Beximco Pharmaceuticals Confirms Reports of Potential Board Changes | MT |
| 26/06 | Beximco suspension lifted; M1 payment date extension | AN |
| Market Cap | 6.23TCr 51Cr 45Cr 42Cr 38Cr 72Cr 4.87TCr 72Cr 504.23Cr 196.12Cr 2.49TCr 189.7Cr 185.63Cr 7.99TCr | P/E 2026 * |
7.19x | P/E 2027 * | 6.28x |
|---|---|---|---|---|---|
| Enterprise Value | 6.23TCr 51Cr 45Cr 42Cr 38Cr 72Cr 4.87TCr 72Cr 504.23Cr 196.12Cr 2.49TCr 189.7Cr 185.63Cr 7.99TCr | EV / Sales 2026 * |
1.14x | EV / Sales 2027 * | 1.02x |
| Free-Float |
85.91% | Yield 2026 * |
4.31% | Yield 2027 * | 4.94% |
| 1 day | -2.24% | ||
| 1 week | -5.74% | ||
| Current month | -5.42% | ||
| 1 month | -8.88% | ||
| 3 months | -7.30% | ||
| 6 months | +22.24% | ||
| Current year | +36.73% |
| 1 week | 138.5 |  | 150.2 |
| 1 month | 138.5 | | 153.8 |
| Current year | 99.5 | | 158.5 |
| 1 year | 99.5 | | 158.5 |
| 3 years | 64.2 | | 158.5 |
| 5 years | 64.2 | | 253.8 |
| 10 years | 47.36 | | 255.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iqbal Ahmed
CEO | Chief Executive Officer | - | 04/03/2024 |
| Director of Finance/CFO | 63 | 01/01/2003 | |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 19/06/2009 | |
| Director/Board Member | - | 01/02/2010 | |
Iqbal Ahmed
BRD | Director/Board Member | - | 01/01/1985 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.24% | -5.74% | +17.91% | -4.51% | 52Cr | |
| +1.26% | -2.29% | +36.97% | +104.79% | 1,01900Cr | |
| +0.73% | -4.78% | +35.41% | +61.62% | 61TCr | |
| +0.35% | +1.29% | +15.86% | +79.90% | 47TCr | |
| +1.72% | -4.92% | +59.84% | +36.64% | 34TCr | |
| +0.26% | -1.58% | +21.97% | +41.79% | 34TCr | |
| +0.60% | -3.48% | +11.37% | +34.33% | 27TCr | |
| +1.65% | -4.27% | -5.47% | +9.69% | 24TCr | |
| -0.09% | -4.97% | +36.88% | +50.52% | 22TCr | |
| -0.28% | -4.66% | +26.99% | +92.98% | 18TCr | |
| Average | +0.41% | -3.81% | +25.77% | +50.77% | 36.83TCr | |
| Weighted average by Cap. | +0.89% | -3.51% | +29.67% | +67.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.48TCr 44Cr 39Cr 37Cr 33Cr 63Cr 4.29TCr 64Cr 443.55Cr 172.52Cr 2.19TCr 166.87Cr 163.29Cr 7.03TCr | 6.13TCr 50Cr 44Cr 41Cr 37Cr 71Cr 4.79TCr 71Cr 496.06Cr 192.94Cr 2.45TCr 186.63Cr 182.62Cr 7.86TCr |
| Net income | 866.2Cr 7.03Cr 6.24Cr 5.84Cr 5.29Cr 10Cr 677.6Cr 10Cr 70Cr 27Cr 345.67Cr 26Cr 26Cr 1.11TCr | 991.9Cr 8.05Cr 7.15Cr 6.69Cr 6.06Cr 11Cr 775.93Cr 12Cr 80Cr 31Cr 395.83Cr 30Cr 30Cr 1.27TCr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/26/06 | BDT 139.60 | -2.24% | 5,12,993 |
| 05/26/05 | BDT 142.80 | -1.18% | 2,80,589 |
| 04/26/04 | BDT 144.50 | -1.83% | 6,32,681 |
| 01/26/01 | BDT 147.20 | -0.27% | 3,91,420 |
| 30/26/30 | BDT 147.60 | +0.27% | 14,89,179 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BXPHARMA Stock
Select your edition
All financial news and data tailored to specific country editions
